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The α-MRE is the major regulatory element responsible for the expression of human α-like globin genes. It is genetically
polymorphic, and six different haplotypes, named A to F, have been identified in some population groups from Europe, Africa and
Asia and in native Indians from two Brazilian Indian tribes. Most of the mutations that constitute the α-MRE haplotypes are
located in flanking sequences of binding sites for nuclear factors. To our knowledge, there are no experimental studies
evaluating whether such variability may influence the α-MRE enhancer activity. We analyzed and compared the expression of
luciferase of nine constructs containing different α-MRE elements as enhancers. Genomic DNA samples from controls with A
(wild-type α-MRE) and B haplotypes were used to generate C-F haplotypes by site-directed mutagenesis. In addition, three other
elements containing only the G→A polymorphism at positions +130, +199, and +209, separately, were also tested. The different
α-MRE elements were amplified and cloned into a plasmid containing the luciferase reporter gene and the SV40 promoter and
used to transiently transfect K562 cells. A noticeable reduction in luciferase expression was observed with all constructs
compared with the A haplotype. The greatest reductions occurred with the F haplotype (+96, C→A) and the isolated
polymorphism +209, both located near the SP1 protein-binding sites believed not to be active in vivo. These are the first analyses
of α-MRE polymorphisms on gene expression and demonstrate that these single nucleotide polymorphisms, although outside
the binding sites for nuclear factors, are able to influence in vitro gene expression.
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Introduction
The erythroid lineage-specific and developmental stage-
specific expression of the human α-like globin genes is
controlled by an element located 40 kb upstream of the ζ-
globin gene on chromosome 16p13.3, known as HS-40 or
α-major regulatory element (α-MRE) (1,2). It has been
demonstrated that the α-MRE confers high levels of ex-
pression to the α-like globin genes and behaves as an
enhancer for the promoter activity of these genes (2-9).
The α-MRE is genetically polymorphic and its variabil-
ity has been studied by Harteveld et al. (10) in seven
population groups from Africa (Bantu-speaking and Pyg-
mies), Europe (Dutch and Italians) and Asia (Chinese,
East Indians, and Indonesians), and by Ribeiro et al. (11) in
two Brazilian Indian tribes. Six haplotypes, denoted A to F,
were detected. Only the A and B haplotypes are present in
all groups analyzed. The other haplotypes (C to F) are
present in low frequencies and in specific populations
(10,11).
Most α-MRE single nucleotide polymorphisms (SNPs)
are located either between binding sites for transcriptional
factors or in a site considered not to be active in vivo
(3,8,10,12). There are no studies evaluating whether these
Brazilian Journal of Medical and Biological Research (2009) 42: 783-786
ISSN 0100-879X Short Communication
784
Braz J Med Biol Res 42(9) 2009
D.M. Ribeiro et al.
www.bjournal.com.br
natural mutations influence gene expression or not. Since
clinical studies associating the α-MRE haplotypes with α-
gene expression levels and hematological features are diffi-
cult to carry out due to the low frequencies of most haplo-
types, the aim of the present study was to compare the in
vitro gene expression of constructs having all six different α-
MRE haplotypes as enhancers, in addition to the SV40
promoter and to the luciferase reporter gene. These con-
structs were used to transiently transfect K562 cells.
Material and Methods
Plasmid constructs
The α-MRE core fragment (350 bp) was first amplified by
the polymerase chain reaction (PCR) (10) using genomic
DNA from two controls: one with the wild-type α-MRE (A
haplotype) and the other with the B haplotype. These frag-
ments were used to generate the other haplotypes (C-F) and
three other elements containing the +130, +199, and +209
polymorphisms separately by site-directed mutagenesis in a
two-step PCR. In the first step, primer pairs A/D and B/C
were used to amplify overlapping halves of the mutant
segment; the two PCR products were combined and the full-
length mutant sequence was amplified with primer pair A/B
(oligonucleotide sequences in Table 1). The products were
sequenced to determine if any additional mutations had
been introduced during amplification.
The different amplified elements were cloned into a
pGL2-promoter plasmid (Promega, USA) consisting of an
SV40 promoter linked to the firefly luciferase reporter gene.
The enhancer activity of the α-MRE on the SV40 promoter is
similar to its activity on α-globin gene promoters (4).
Plasmid DNA was grown in DH5α bacteria and purified
(Qiagen Plasmid Maxiprep, Germany). The correct se-
quences of the constructs were confirmed by sequencing.
Only constructs containing the α-MRE in the same geno-
mic orientation as the SV40 promoter were used in the
transfection assays.
Nine constructs were obtained: one with the A haplo-
type, five with the other haplotypes (B-F) and three with the
+130, +199 and +209 polymorphisms separately.
Cell culture and DNA transfection assay
Cells from the human K562 erythroleukemia cell line
were grown in RPMI 1640 medium supplemented with 10%
fetal bovine serum and penicillin-streptomycin (GIBCO, USA)
(37°C, 5% CO2) at a density of 1 x 106 cells per mL (13).
Approximately 8 x 106 cells were transfected in suspension
by electroporation (250 volts, 975 μF, 9 ms) with 20 μg of
each construct and 1 μg of pRL-TK plasmid (Promega). The
vector pRL-TK, which expresses Renilla luciferase, was
used as an internal control for electroporation.
Luciferase assays
The cells were harvested 24 h post-transfection. The
firefly and Renilla luciferase activities were measured in
the cell lysates using a luminometer (Turner Designs,
USA) and the dual luciferase reporter assay (Promega).
The light output was measured for 15 s. The vectors pGL2-
Basic and pGL2-Control (Promega) were used as negative
and positive expression controls, respectively.
The firefly luciferase activity expressed by the con-
structs was normalized against the Renilla luciferase activ-
ity, expressed from the co-transfected pRL-TK vector.
Electroporations were performed in triplicate, each experi-
ment was repeated three times and the average expres-
sion level for each construct is reported in relative lumines-
cence units.
Results and Discussion
The results of the transient transfection experiments
are summarized in Figure 1. Analysis of variance (ANOVA)
detected a significant decrease (P = 0.0025) with all the
enhancers compared with the A haplotype. Interestingly,
the greatest reductions of α-MRE function in K562 cells
were observed with the constructs containing the isolated
polymorphisms +96 and +209, both located near the SP1
protein-binding sites believed not to be active in vivo.
These mutations were able to repress the α-MRE en-
hancer activity almost completely.
Previous studies using site-directed mutagenesis in
the nuclear protein-binding sites and transient expression
Table 1. Primer sequences for site-directed mutagenesis.
A and C indicate the forward primers (Ref. 10); B and D indicate
the reverse primers; bold letters indicate the nucleotide substitu-
tions in relation to the wild-type sequence.
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assays demonstrated that the GATA-1 sites (B, C and D),
both NF-E2 sites (5' and 3') and the CACC box (II) posi-
tively regulate the α-MRE function in α-like globin genes
expression in K562 cells (14,15). Mutations in each of the
six protein-binding sites reduced the gene expression by
50 to 90% (13).
Recently, Vernimmen et al. (16) proposed a model to
explain the mouse α-globin locus activation during the
erythroid differentiation process. According to it, active
transcription first requires the recruitment of regulatory
proteins and RNA polymerase II to the remote regulatory
sequences; only late in the differentiation process is the
transcriptional machinery recruited to the α-globin promot-
ers with looping occurring between the regulatory ele-
ments and the α-globin genes. De Gobbi et al. (17) inves-
tigated gene activation in human erythropoiesis. All known
cis-acting regulatory elements in the human α-cluster were
identified and no additional erythroid-specific regulatory
elements were found (reviewed in Ref. 18).
We analyzed the effects of the SNPs located in flanking
sequences of α-MRE binding sites on the luciferase re-
porter gene expression in K562 cells. This kind of study
allowed the simultaneous comparison of all base substitu-
tions described in the α-MRE so far. In the transient ex-
pression assay employed here, they substantially reduced
gene expression.
Since this type of assay reflects exactly the structure-
function relationship during the final stage of transcrip-
tional activation, when promoters and regulatory elements
are already physically associated (15), one possible expla-
nation for the present results is that the α-MRE polymor-
phisms may be causing a reduction of the binding affinity of
regulatory proteins to DNA, consequently altering the con-
figuration and function of the regulatory element and thus
modifying the luciferase gene expression.
The greatest reductions of luciferase gene expression
were observed with the constructs containing polymor-
phisms located near the SP1 protein-binding sites consid-
ered not to be active in vivo. These sites, however, have
been well-conserved during evolution (2). Since an en-
hancer can sometimes function as a silencer (19,20), the
drastic negative regulatory effect of the polymorphisms
next to the CACC boxes suggests that these sites were
occupied by factors other than SP1 involved in the positive
or negative regulation of the α-MRE function in K562 cells.
Our results represent the first analysis of the effects of α-
MRE polymorphisms on gene expression. They indicate that
these SNPs, although outside the binding sites for nuclear
factors, are able to influence the enhancer activity of the α-
Figure 1. Effect of polymorphisms of the α-major regulatory
element (α-MRE) HS-40 on in vitro gene expression. A, Lu-
ciferase activity of the different gene constructions in K562 cells.
Data are reported as means ± SD relative luminescence units. B,
Relative luciferase activities. The medians are shown as a per-
centage of the activity of the construction containing the wild-
type α-MRE (A haplotype), defined as 100%. The gene construc-
tions correspond to haplotypes A (wild-type) to F and to 3 iso-
lated polymorphisms (G→A at positions 130, 199 and 209) of the
cloned α-MRE fragment.
MRE. They may be related, in vivo, to variable levels of
expression of the α-globin genes and α-thalassemia, espe-
cially in regions under malarial selective pressure. The
hematological phenotype, however, will depend on the final
genotype of each individual and compensatory mechanisms
and epigenetic regulations occurring in complex organisms.
Further experiments identifying DNA-protein interactions at
these polymorphic sites should help to understand how
these polymorphisms influence gene regulation.
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